$PVCT Provectus News Provectus Lists Partnerin
Post# of 22711
![Avatar](/images/ProfileImages/984076804_464_129571309_0017.gif)
Provectus Lists Partnering Opportunities for PV-10 and PH-10
Wednesday October 22, 2014
Partnering opportunities for PV-10 and PH-10 have been listed in the Pipeline section of IMS LifeCycle R&D Focus Drug News (Vol 23 No 42 page 11). Provectus is pursuing partnering opportunities in the development of PV-10 in China, Russia and India and is also looking for global partners to conduct clinical evaluation of PV-10 in combination with other anti-cancer agents. Additionally, Provectus is open to discussions regarding partnerships and collaborations in the development of PH-10, an investigational therapy for inflammatory skin diseases, including psoriasis, dermatitis and eczema.
A reprint of the IMS LifeCycle newsletter is available from the Provectus website at:
IMS LifeCycle R&D Focus Drug News Vol. 23 No. 42
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
![937206596_images.jpg](https://investorshangout.com/images/MYImages/937206596_images.jpg)